Patient-centered toolkit (PCTK) improves communication between patients, caregivers, and health care team
A novel web-based, patient-centered toolkit (PCTK) helped patients develop their plan of care.
The rates of contralateral prophylactic mastectomy (CPM) among men with breast nearly doubled between 2004 and 2011.
Prescription drug that is commonly used to treat fungal infections in lung transplant recipients may significantly increase the risk for skin cancer.
No new safety signals were identified for long-term denosumab therapy in patients with metastatic breast or prostate cancer and bone metastases.
Children with cancer receiving methotrexate had a poor complete chemotherapy-induced nausea and vomiting (CINV) rate.
Variation in Medicare reimbursement for radiation therapy not attributed to patient or cancer characteristics
Differences in radiation therapy costs for Medicare patients often have little to do with patient specifics, researchers found.
Regular consumption of caffeinated coffee may help prevent the return of colon cancer after treatment and improve the chances of a cure, according to a new, large study.
Researchers have discovered that determining a tumor's medulloblastoma subgroup can be achieved noninvasively, using magnetic resonance spectroscopy (MRS).
Recurrent exposure to antibiotics may increase the risk for cancer in specific organ sites.
Androgen deprivation therapy negative impacts the mood of patients with prostate cancer.
Early FDG-PET adapted treatment improves the outcome of early FDG-PET-positive patients with stages I/II Hodgkin lymphoma, according to the results of a randomized trial.
An increasing number of oncology/hematology treatments will consist of oral oncolytics, and oncology programs are needed to manage the treatment of patients following these regimens.
BALTIMORE, MD—For more aggressive cases of non-Hodgkin lymphoma (NHL), posttreatment surveillance with molecular imaging could mean the early start of a new, life-saving treatment. This was presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2015 Annual Meeting.
CHICAGO, IL—Functional subtyping with a multigene classifier resulted in 1 in 5 tumors being reclassified compared with conventional immunohistochemistry/fluorescent in situ hybridization (IHC/FISH) analysis. This study was presented at the 2015 American Society for Clinical Oncology (ASCO) Annual Meeting.
Expanded surgical margins during a partial mastectomy could be beneficial for patients, preventing further surgery.
- New biomarker in breast and prostate cancer may help identify patients who will respond to taxanes
- What are immune checkpoints and how do they work?
- Among patients with myeloma undergoing chemo, high exercise compliance linked with reduced fatigue
- Efficacy and safety of docetaxel for advanced non-small-cell lung cancer: A meta-analysis of Phase III randomized controlled trials
- New combination treatment effective against cutaneous metastatic melanoma
- Religiousness and spirituality have a significant impact on cancer patients' overall health and outcomes
- Dietary intervention primes triple-negative breast cancer cells for targeted therapy
- Lung cancer patients who stop smoking live longer
- Study uses dog sledding to demonstrate benefits of adapted physical activities for children with cancer
- Review examines strategies for hospital room surface cleanliness
- Patient-centered toolkit (PCTK) improves communication between patients, caregivers, and health care team
- Prophylactic surgery rates among men with breast cancer nearly double
- Fungal infection drug for lung transplant recipients may increase cancer, death risk
- Long-term denosumab therapy safe for patients with breast, prostate cancer
- Children receiving intermediate, high dose MTX experience poor CINV control
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|